Improved quality of life and pain relief in mature horses with osteoarthritis after oral transmucosal cannabidiol oil administration as part of an analgesic regimen
- PMID: 38379920
- PMCID: PMC10876772
- DOI: 10.3389/fvets.2024.1341396
Improved quality of life and pain relief in mature horses with osteoarthritis after oral transmucosal cannabidiol oil administration as part of an analgesic regimen
Abstract
The aim of this study was to evaluate the effect of oral cannabidiol (CBD) administration in addition to a conventional analgesic protocol on the clinical signs of 20 horses with mild joint osteoarthritis. The horses were randomly assigned to either the control group (C group) or the cannabidiol group (CBD group). Both groups were treated with phenylbutazone for 5 days. The CBD group received 0.03 mg/kg cannabidiol in hemp oil orally once daily for 14 days in addition to phenylbutazone treatment. All subjects were monitored for clinical parameters, oxidative status and blood counts. Pain and quality of life were also assessed using the Horse Chronic Pain Scale (HCPS). The CBD group showed a significant reduction in heart rate, respiratory rate, white blood cell count and oxidative stress (malondialdehyde lipid peroxidation). A significant reduction in HCPS scores was seen in both groups. Lower scores were recorded in the CBD group (3 med; range: 2/4) than in the C group (7 med; range: 4/10). The addition of a cannabidiol-based product to an analgesic protocol was well tolerated and showed positive effects on the treated subjects, improving their quality of life and pain relief.
Keywords: cannabidiol; hemp oil; horses; oral transmucosal; osteoarthritis; pain; quality of life.
Copyright © 2024 Interlandi, Tabbì, Di Pietro, D’Angelo, Costa, Arfuso, Giudice, Licata, Macrì, Crupi and Gugliandolo.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.
Figures
Similar articles
-
Oral Transmucosal Cannabidiol Oil Formulation as Part of a Multimodal Analgesic Regimen: Effects on Pain Relief and Quality of Life Improvement in Dogs Affected by Spontaneous Osteoarthritis.Animals (Basel). 2020 Aug 26;10(9):1505. doi: 10.3390/ani10091505. Animals (Basel). 2020. PMID: 32858828 Free PMC article.
-
Role of cannabidiolic acid or the combination of cannabigerol/cannabidiol in pain modulation and welfare improvement in horses with chronic osteoarthritis.Front Vet Sci. 2024 Dec 10;11:1496473. doi: 10.3389/fvets.2024.1496473. eCollection 2024. Front Vet Sci. 2024. PMID: 39720409 Free PMC article.
-
Effects of a Supplement Containing Cannabidiol (CBD) on Sedation and Ataxia Scores and Health.J Equine Vet Sci. 2022 Oct;117:104085. doi: 10.1016/j.jevs.2022.104085. Epub 2022 Jul 23. J Equine Vet Sci. 2022. PMID: 35882292
-
Clinicians' Guide to Cannabidiol and Hemp Oils.Mayo Clin Proc. 2019 Sep;94(9):1840-1851. doi: 10.1016/j.mayocp.2019.01.003. Epub 2019 Aug 22. Mayo Clin Proc. 2019. PMID: 31447137 Review.
-
Efficacy and safety of cannabidiol for the treatment of canine osteoarthritis: a systematic review and meta-analysis of animal intervention studies.Front Vet Sci. 2023 Sep 15;10:1248417. doi: 10.3389/fvets.2023.1248417. eCollection 2023. Front Vet Sci. 2023. PMID: 37781283 Free PMC article.
Cited by
-
Effect of orally administered cannabidiol oil on daily tonometric curve in healthy Italian Saddle horses.PLoS One. 2025 May 28;20(5):e0325191. doi: 10.1371/journal.pone.0325191. eCollection 2025. PLoS One. 2025. PMID: 40435047 Free PMC article.
-
Limited 12-hour pharmacokinetic assessment of CBD and CBDA isolates compared to their full-spectrum extracts in healthy adult beagles.Front Vet Sci. 2025 Aug 12;12:1639846. doi: 10.3389/fvets.2025.1639846. eCollection 2025. Front Vet Sci. 2025. PMID: 40874201 Free PMC article.
-
Analgesic efficacy of tapentadol in chronic joint disorders in horses: plasma serotonin concentration and adrenocortical response as biomarkers of pain-induced stress.Front Vet Sci. 2024 Dec 17;11:1505398. doi: 10.3389/fvets.2024.1505398. eCollection 2024. Front Vet Sci. 2024. PMID: 39742317 Free PMC article.
-
Assessing Facial Thermal Nociceptive Response in Female Dogs After Elective Ovariohysterectomy Anesthetized with Isoflurane and Treated with Cannabidiol and Meloxicam Analgesia.Animals (Basel). 2025 Jan 15;15(2):227. doi: 10.3390/ani15020227. Animals (Basel). 2025. PMID: 39858227 Free PMC article.
-
Pharmacokinetics of a single oral administration of two cannabidiol formulations in fed and fasted horses.Front Vet Sci. 2025 Feb 19;12:1515833. doi: 10.3389/fvets.2025.1515833. eCollection 2025. Front Vet Sci. 2025. PMID: 40046423 Free PMC article.
References
-
- Brioschi FA, Di Cesare F, Gioeni D, Rabbogliatti V, Ferrari F, D'Urso ES, et al. . Oral transmucosal cannabidiol oil formulation as part of a multimodal analgesic regimen: effects on pain relief and quality of life improvement in dogs affected by spontaneous osteoarthritis. Animals. (2020) 10:1505. doi: 10.3390/ani10091505, PMID: - DOI - PMC - PubMed
-
- Alves ALG, Fonseca BPA, Thomassian A, Nicoletti JLM, Hussni CA, Silveira CA. Lombalgia em equinos. Braz J Vet Res Anim Sci. (2007) 44:191–9. doi: 10.11606/issn.1678-4456.bjvras.2007.26638 - DOI
LinkOut - more resources
Full Text Sources